Buscar
Resultados de la búsqueda
- CIMAvax-EGF vaccine Predictor Phase IV
-
... MD, First degree specialist in Oncology Affiliation: ... , Juan Carlos Brosales, MD, First Degree Especilist in Oncology Havana, Luis Galván ...
Clinical Trials - CIM - 19/07/2023 - 3:32pm
- Vacuna CIMAvax-EGF Predictor fase IV
-
... NCCN Clinical Practice Guidelines in Oncology. NSCLC. Version I. 2013 www.nccn.org ...
Ensayos Clínicos - CIM - 19/07/2023 - 3:32pm
- 1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma
-
... MD. Second degree specialist in Oncology, INOR MD. Second degree specialist in Hematology, HHA ... Havana, National Institute of Oncology and Radiobiology (INOR) Havana, “Hermanos Ameijeiras” Hospital ...
Clinical Trials - CIM - 19/07/2023 - 3:32pm
- RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma
-
... Havana, National Institute of Oncology and Radiobiology, Elías A. Gracia Medina, MD, first degree specialist in Oncology Havana, Hospital ...
Clinical Trials - CIM - 19/07/2023 - 3:30pm
- Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations
-
... First Degree Specialist in Oncology Affiliation: ... Havana, National Institute of Oncology and Radiobiology (INOR), Yoana Flores Perez, MD. First Degree ...
Clinical Trials - CIM - 19/07/2023 - 3:26pm
- CIMAvax-EGF in different maintenance schemes
-
... Second Degree Specialist in Oncology Affiliation: ...
Clinical Trials - CIM - 19/07/2023 - 3:26pm
- Phase I/II trial with the mutein no alfa of IL-2
-
... Second Degree Specialist in Oncology Affiliation: National Institute for Oncology and Radiobiology (INOR) Postal ...
Clinical Trials - CIM - 19/07/2023 - 3:22pm
- Dose scale-up and cohort expansion with the therapeutic mAb 14F7
-
... Second Degree Specialist in Oncology Affiliation: National Institute for Oncology and Radiobiology (INOR) Postal ...
Clinical Trials - CIM - 19/07/2023 - 3:22pm
- Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT)
-
... First degree specialist in Oncology. Affiliation: ... Barbara Iglesias Castillo, MD, Second Degree Specialist in Oncology. Research ethics committees: ...
Clinical Trials - CIM - 19/07/2023 - 3:22pm
- Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III.
-
... First Degree Specialist in Oncology Affiliation: ...
Clinical Trials - CIM - 19/07/2023 - 3:20pm